Abstract
Animal mast cell models demonstrate direct histamine release by protamine. Investigators have proposed that protamine also releases histamine in man. We studied the effects of protamine alone and heparinprotamine mixtures on minced lung tissue for evidence of histamine release. We were unable to demonstrate the release of histamine despite positive anti-IgE controls. Nonimmunologic histamine release from human lung appears unlikely as a mechanism for portamine reactions in man.
Similar content being viewed by others
References
J.C. Horrow,Protamine: A review of its toxicity. Anesth. Analg.64, 348–361 (1985).
R.W.M. Frater, Y. Oka, Y. Hong, T. Tsubo, P.G. Loubser and R. Masone,Protamine-induced circulatory changes. J. Thorac. Cardiovasc. Surg.87, 687–692 (1984).
R.P. Schleimer, D.W. MacGlashan Jr. and S.P. Peters,Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J. Allergy Clin. Immunol.74, 473–481 (1984).
S. Schnitzler, H. Renner and U. Pfuller,Histamine release from rat mast cells induced by protamine sulfate and polyethylene amine. Agents and Actions11, 73–74 (1981).
B.A. Faraj, G.R. Gottlieb, V.M. Camp, M. Kutner and P. Lolies,Development of a sensitive radioassay of histamine for in vitro allergy testing. J. Nucl. Med.25, 56–63 (1983).
W.P. Fiser, J.E. Fewell, D.E. Hill, R.W. Barnes and R.C. Read,Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin. J. Thorac. Cardiovasc. Surg.89, 63–70 (1985).
M. Kaliner, R. Sigler, R. Summers and J.H. Shelhamer,Effects of infused histamine: correlation of plasma histamine levels and symptoms. J. Allergy Clin. Immunol.69, 283–289 (1982).
S.P. Peters, E.S. Schulman, R.P. Schleimer, D.W. Macglashan, H.H. Newball and L.M. Lichtenstein,Dispersed human lung mast cells: pharmacologic aspects and comparison with human lung tissue fragments. Am. Rev. Respir. Dis.125, 1034–1039 (1982).
J.M. Hermens, J.M. Ebertz, J.M. Hanifin and C.A. Hirshman.Comparison of histamine release in human skin mast cells by morphine, fentanyl, and oxymorphone. Anesthesiology62, 124–129 (1983).
M.D. Tharp, A. Kagey-Sobotka, C.C. Fox, G. Marone, L.M. Lichtenstein and T.J. Sullivan,Functional heterogeneity of human mast cells from different anatomic sites: In vitro responses to morphine sulfate. J. Allergy. Clin. Immunol.79, 646–653 (1987).
D.R. Morel, W.M. Zapol, S.J. Thomas, E.M. Kitain, D.R. Robinson, J. Moss, D.E. Chenoweth and E. Lowenstein,C5a and thromboxane generation association with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Anesthesiology66, 597–604 (1987).
J.H. Levy, I.M. Schweiger, J.R. Zaidan, B.A. Faraj and W.S. Weintraub,Evaluation of patients at risk for protamine reactions. J. Thorac. Cardiovasc. Surg. in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, J.H., Faraj, B.A., Zaidan, J.R. et al. Effects of protamine on histamine release from human lung. Agents and Actions 28, 70–72 (1989). https://doi.org/10.1007/BF02022982
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02022982